Scarica l'app Stockscreener
53.54
1.83%
-1.00
Pre-mercato:
53.70
0.16
+0.30%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$54.54
Aprire:
$54.5
Volume 24 ore:
707.62K
Relative Volume:
0.92
Capitalizzazione di mercato:
$2.58B
Reddito:
$1.36B
Utile/perdita netta:
$123.81M
Rapporto P/E:
22.22
EPS:
2.41
Flusso di cassa netto:
$20.35M
1 W Prestazione:
-3.06%
1M Prestazione:
-28.39%
6M Prestazione:
-18.26%
1 anno Prestazione:
-29.16%
Intervallo 1D:
$53.25
$54.72
Intervallo di 1 settimana:
$53.25
$55.71
Portata 52W:
$50.68
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Nome
Haemonetics Corp
Settore
Industria
Telefono
(781) 848-7100
Indirizzo
125 SUMMER STREET, BOSTON, MA
Confronta HAE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
53.54 | 2.63B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Reiterato | Barrington Research | Outperform |
| 2025-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-06-26 | Iniziato | Robert W. Baird | Outperform |
| 2025-02-07 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Iniziato | JP Morgan | Overweight |
| 2024-11-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Iniziato | CL King | Buy |
| 2024-09-11 | Iniziato | BofA Securities | Neutral |
| 2024-09-10 | Iniziato | BTIG Research | Buy |
| 2024-06-12 | Aggiornamento | Needham | Hold → Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-01-27 | Downgrade | Needham | Buy → Hold |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Ripresa | Raymond James | Outperform |
| 2021-06-17 | Iniziato | Citigroup | Buy |
| 2021-05-14 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Iniziato | Needham | Buy |
| 2019-08-07 | Reiterato | Barrington Research | Outperform |
| 2019-05-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Reiterato | Barrington Research | Outperform |
| 2018-08-09 | Reiterato | Barrington Research | Outperform |
| 2018-02-07 | Reiterato | Barrington Research | Outperform |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Reiterato | Barrington Research | Outperform |
| 2017-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Reiterato | The Benchmark Company | Hold |
| 2016-09-20 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Downgrade | Sidoti | Buy → Neutral |
| 2016-08-02 | Reiterato | Jefferies | Buy |
| 2016-08-02 | Reiterato | The Benchmark Company | Hold |
Mostra tutto
Haemonetics Corp Borsa (HAE) Ultime notizie
What candlestick patterns are forming on Haemonetics CorporationJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Is Haemonetics Corporation a candidate for recovery playTrade Volume Summary & Weekly High Momentum Picks - Newser
Is Haemonetics Corporation a top pick in the sectorIndex Update & AI Based Buy/Sell Signal Reports - خودرو بانک
How to escape a deep drawdown in Haemonetics CorporationMarket Trend Summary & Entry Point Confirmation Alerts - Newser
Can Haemonetics Corporation reach all time highs this yearWeekly Trade Review & Daily Entry Point Trade Alerts - خودرو بانک
Will Haemonetics Corporation benefit from AI trendsGap Up & Safe Entry Zone Identification - خودرو بانک
Is Haemonetics Corporation stock ready for a breakout2025 Key Lessons & Weekly Watchlist for Hot Stocks - Newser
Published on: 2025-09-02 04:04:11 - Newser
Is this a good reentry point in Haemonetics CorporationOil Prices & Precise Buy Zone Identification - Newser
Can Haemonetics Corporation weather a recession2025 Trade Ideas & AI Driven Price Forecasts - خودرو بانک
Analyzing Haemonetics Corporation with multi timeframe chartsJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
What moving averages say about Haemonetics CorporationTrade Analysis Report & Momentum Based Trading Ideas - Newser
Using Python tools to backtest Haemonetics Corporation strategiesLong Setup & Expert Verified Movement Alerts - Newser
Can machine learning forecast Haemonetics Corporation recoveryQuarterly Portfolio Report & Real-Time Buy Zone Alerts - Newser
Can Haemonetics Corporation hit a new high this monthPortfolio Performance Report & Long Hold Capital Preservation Plans - Newser
Should You Be Excited About Haemonetics Corporation's (NYSE:HAE) 19% Return On Equity? - Yahoo Finance
Volatility clustering patterns for Haemonetics Corporation2025 Price Action Summary & Detailed Earnings Play Alerts - Newser
Published on: 2025-09-01 20:53:08 - Newser
Analyzing net buyer seller activity in Haemonetics CorporationJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Why Haemonetics Corporation stock attracts strong analyst attentionMarket Performance Report & Advanced Technical Signal Analysis - Newser
Building trade automation scripts for Haemonetics Corporation2025 Big Picture & Real-Time Price Movement Reports - Newser
Is Haemonetics Corporation stock entering bullish territory2025 Sector Review & Technical Confirmation Trade Alerts - Newser
Haemonetics Corporation $HAE Shares Sold by Northern Trust Corp - Defense World
Zacks Research Lowers Earnings Estimates for Haemonetics - Defense World
Evaluating Haemonetics Corporation with trendline analysisJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser
Haemonetics Corporation Approaches Support With Recovery in SightOil Prices & High Accuracy Swing Entry Alerts - beatles.ru
Haemonetics Corp Azioni (HAE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
1.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):